Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2021-11-09 00:00:00 ET · period of report 2021-11-05 · accession 0001437749-21-025974 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-09 | 2021-11-05 | NHC | Flatt Stephen Fowler | CEO, Dir | F - Tax | $76.35 | -38.6K | 52.1K | -43% | -$2.95M |
| D | 2021-11-09 | 2021-11-05 | NHC | Flatt Stephen Fowler | CEO, Dir | M - OptEx | $72.94 | +40.0K | 90.7K | +79% | +$2.92M |
| D | 2021-11-09 | 2021-11-05 | NHC | Flatt Stephen Fowler | CEO, Dir | M - OptEx | $0.00 | -40.0K | 5,000 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Shares of Common Stock held in my name | 2021-11-05 | F | D | 38,633 | $76.35 | 52,095 | D | — | — | (F2) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. (F3) Total amount of shares beneficially owned following transactions reported on this form. |
| 2 | Common | Shares of Common Stock held in my name | 2021-11-05 | M | A | 40,000 | $72.94 | 90,728 | D | — | — | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 3 | Derivative | Option to Purchase Common Stock | 2021-11-05 | M | D | 40,000 | $0.00 | 5,000 | D | $72.94 · 2022-02-09 to 2022-03-11 | 45,000 Common Stock | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |